SCHEMBL9290266

SCHEMBL9290266

CCCN(C)c1nc2c(c(=O)n(Cc3ccc4nccnc4c3)c(=O)n2C)n1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.41
▸ TP53 P04637 2/20 0.41
▸ ALDH1A1 P00352 6/20 0.39
▸ HIF1A Q16665 4/20 0.39
▸ HPGD P15428 1/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAOB P27338 2/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ PKM P14618 2/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ LMNA P02545 2/20 0.38
▸ STAT6 P42226 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8273216 0.82 DPP4 (0.46) ALDH1A1HIF1AHPGD
SCHEMBL13955148 0.79 THRB (0.37) MAPTTP53ALDH1A1HIF1AHPGD
SCHEMBL13955146 0.78 ALDH1A1 (0.40) MAPTALDH1A1HIF1AHPGDSMN1; SMN2
SCHEMBL4486312 0.77 DPP4 (0.45) MAPTALDH1A1HPGDHTTTSHR
SCHEMBL8273218 0.77 DPP4 (0.45) —
SCHEMBL4486305 0.77 DPP4 (0.45) MAPTALDH1A1HPGDHTTTSHR
SCHEMBL13955212 0.76 DPP4 (0.40) MAPTALDH1A1HIF1AMAOBHTT
SCHEMBL9290323 0.74 HSD17B10 (0.43) MAPTTP53ALDH1A1MAOBHTT
SCHEMBL3975290 0.73 DPP4 (0.50) MAPTALDH1A1HIF1AHPGDSMN1; SMN2
SCHEMBL13954985 0.73 ALDH1A1 (0.37) MAPTTP53ALDH1A1HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797093-B1 NOVEL 3-METHYL-7-BUTINYL-XANTHINES, PRODUCTION THEREOF, AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM INT (DE) 2012-05-30 — — EP disclosed
Send feedback